FDA Qualified Health Claims for Yogurt and Type 2 Diabetes

Trending News

Trump Administration Issues AI Action Plan and AI Executive Orders

Winning the Race: America’s AI Action Plan

Innovation Over Regulation – Trump Unveils America’s AI Action Plan

Caught in the Act: Practical and Legal Considerations When Executives’ Office Love Affair Exposed

Florida’s CHOICE Act Becomes Law, Enhancing Certain Non-Compete Agreements

Labor Secretary Lifts Abeyance on OFCCP Disability and Veteran Matters

In Case You Missed It: DOL Prohibited From Collecting Liquidated Damages in Wage & Hour Pre-Litigation Investigations

SEC’s New Concept Release on Foreign Private Issuer Standards

What Regulated Businesses Should Know About the Supreme Court’s Recent NEPA Decision

NEW ATDS BATTLEGROUND: Texas Passes HUGE NEW AMENDMENT to Its State Telemarketing Law Reviving The Risk of Autodialer Cases

Food and Drug Law at Keller and Heckman

Email

202-434-4100

Bio and Articles

Find Your Next Job !

Specialist: Legal Information Center Research

Experienced Family Law Attorney

Associate Litigation Attorney

Explore More Job Openings

FDA Announces Qualified Health Claim for Yogurt and Reduced Risk of Type 2 Diabetes

by: Food and Drug Law at Keller and Heckman of Keller and Heckman LLP - The Daily Intake

Friday, March 1, 2024

Print Mail Download info_icon_img

info_icon_img

On March 1, 2024, the U.S. Food and Drug Administration (FDA) announced in a letter of enforcement discretion that it does not object to the use of certain qualified health claims regarding the consumption of yogurt and reduced risk of type 2 diabetes, provided that the qualified health claims are worded so as not to mislead consumers, and that other factors for the use of the claim are met.
A health claim characterizes the relationship between a substance and a disease or health-related condition. A qualified health claim is supported by scientific evidence, but does not meet the more rigorous “significant scientific agreement” standard required for an authorized health claim.
The letter is in response to a petition submitted on behalf of Danone North America that requested the Agency to review this qualified health claim. The petition also noted that the evidence supports the health effects of yogurt as food rather than related to any single nutrient or compound and thus is independent of fat and sugar content. FDA determined that there is some credible evidence supporting a relationship between yogurt intake and reduced risk of type 2 diabetes, but this evidence is limited.
FDA considers 2 cups (3 servings) per week of yogurt to be the minimum amount for this qualified health claim. FDA intends to consider exercising its enforcement discretion for the following qualified health claims regarding the relationship between yogurt and reduced risk of type 2 diabetes:
- “Eating yogurt regularly, at least 2 cups (3 servings) per week, may reduce the risk of type 2 diabetes. FDA has concluded that there is limited information supporting this claim.”
- “Eating yogurt regularly, at least 2 cups (3 servings) per week, may reduce the risk of type 2 diabetes according to limited scientific evidence.”

Current Public Notices

Post Your Public Notice Today!

PUBLIC NOTICE OF UCC SALE: Whitworth Tool, Inc

Published: 12 August, 2025

PUBLIC NOTICE OF UCC SALE: 777 Partners LLC

Published: 11 August, 2025

PUBLIC NOTICE OF UCC ARTICLE 9 SALE: Membership Interests in RINO 17 LLC

Published: 11 August, 2025

PUBLIC NOTICE OF UCC ARTICLE 9 SALE: LCP Hollywood Lender LLC

Published: 8 August, 2025

PUBLIC NOTICE OF UCC ARTICLE 9 SALE: Selux Diagnostics,Inc

Published: 8 August, 2025

PUBLIC NOTICE OF ASSET SALE: CleanBay Renewables, Inc, and Its Several Subsidiaries

Published: 29 July, 2025

PUBLIC NOTICE OF AUCTION OF ASSETS: Confidential Women’s Resort Wear Company

Published: 28 July, 2025

PUBLIC NOTICE OF RECEIVERSHIP SALE: ENTEGRA CAPITAL LLC AND EC MASTER TRUST

Published: 23 July, 2025

PUBLIC NOTICE OF UCC SALE: Harrisburg Hotel LLC

Published: 21 July, 2025

PUBLIC NOTICE OF UCC SALE: GLP 2206 LLC

Published: 18 July, 2025

PUBLIC NOTICE OF ASSIGNMENT: Common Cents Distributors, LLC

Published: 26 June, 2025

Discover more public notices

Current Legal Analysis

Busted! Melbourne International Film Festival Director Subject to Urgent Interlocutory Injunction Over Moral Rights

by: Chris Round

Your Most Valuable Business Asset Might Not Be What You Think: Trade Secrets for NC Business Owners

by: Gavin B. Parsons , Joseph A. Schouten

USPTO Aims to Boost Patent Eligibility of AI and ML Inventions

by: Michael Fainberg

EC Begins Public Consultation on Biotech Act

by: Lynn L. Bergeson , Carla N. Hutton

EPA Accelerates Review of LVEs

by: Lynn L. Bergeson , Carla N. Hutton

More from Keller and Heckman LLP

FDA Proposes to Extend Compliance Date for Food Traceability Rule

by: Food and Drug Law at Keller and Heckman

Public Comment Period Opens for USDA’s Structural Overhaul

by: Food and Drug Law at Keller and Heckman

FDA Publishes Proposed Rule Lowering Minimum Brix Content of Pasteurized Orange Juice

by: Food and Drug Law at Keller and Heckman

FDA Publishes 2025 Guidance Agenda

by: Food and Drug Law at Keller and Heckman

California Updates EPR Program for Packaging and Food Service Ware

by: Packaging Law at Keller and Heckman

FDA Releases Tool for Toxicity Screening of Chemicals in Food

by: Food and Drug Law at Keller and Heckman

Bonus Depreciation and Fiber Optic Networks

by: Casey Lide , Jackson T. Cherner

CODEX ALIMENTARIUS: Main Outcome of the 18th Committee Session on Contaminants in Food (CCCF18)

by: Christophe Leprêtre

FDA’s Reagan-Udall Foundation Releases Roadmap to Produce Safety

by: Food and Drug Law at Keller and Heckman

FDA Announces FY 2026 User Fees

by: Food and Drug Law at Keller and Heckman

California’s Compostable Labeling Requirement Delayed, Varying Compostable Requirements in State’s Laws Questioned

by: Packaging Law at Keller and Heckman

FDA’s Chemistry Guidance Update Not Expected in 2025

by: Packaging Law at Keller and Heckman

USDA APHIS Updates Petition Review Practices for Genetically Engineered Organisms

by: Food and Drug Law at Keller and Heckman

Supreme Court Stays Reinstatement of CPSC Democratic Commissioners

by: Sheila A. Millar , Antonia Stamenova-Dancheva

U.S. Senate Bill Would Eliminate Self-GRAS Pathway to Market Food Substances

by: Packaging Law at Keller and Heckman

Upcoming Events

Aug

21

2025

Crash Course: How to Acquire and Resuscitate Distressed Companies

Sep

15

2025

Chief Litigation Officer Summit

Sep

15

2025

US General Counsel Summit

Aug

13

2025

TSCA 30/30 - August 13, 2025

Print